HAS vs TRDA · P/E 25, rev $4.75B vs P/E 12, rev $210.8M
Hasbro Inc (HAS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Hasbro Inc (HAS) is a leisure company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
HAS currently screens at market cap $10.75B and trailing P/E 25.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the HAS and TRDA stock pages for the full models.
Not investment advice.